USPTO serial 98353782
PIIX
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- HOFFMAN, CHRISTOPHER J
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PIIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William S. Fultz
William S. Fultz Womble Bond Dickinson (US) LLP555 Fayetteville Street, Suite 1100Raleigh, NC 27601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software application for managing medical or clinical studies; downloadable computer software application for transmitting data, for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for diagnosing and treating patients in the field of health; downloadable electronic data files featuring medical or clinical studies; downloadable electronic data files featuring medical or clinical studies in the field of health; downloadable electronic publications, namely electronic magazines and electronic revues being written articles in the field of health, medical and clinical studies; downloadable mobile application software for transmitting data, for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for diagnosing and treating patients in the field of health; computer software applications for transmitting data, for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for diagnosing and treating patients, downloadable in the field of health; optical data carriers bearing recorded software for transmitting data, for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for diagnosing and treating patients in the field of health; downloadable mobile application software for interacting with patients, for providing medical treatment and testing of patients, for providing remote assistance to patients, and for patient engagement namely, for diagnosing and treating patients; computer software applications, downloadable, for interacting with patients, for providing remote assistance to patients, and for patient engagement namely, for diagnosing and treating patients; downloadable software and computer software applications for transmitting data, for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for diagnosing and treating patients for mobile devices; downloadable computer software applications for use with mobile devices for interacting with patients, for providing remote assistance to patients, and patient engagement namely, for diagnosing and treating patients; downloadable mobile software applications for the transmission of data for interacting with patients, for providing remote assistance to patients and patient engagement, namely for diagnosing and treating patients; optical data carriers bearing recorded software for interacting with patients, for providing remote assistance to patients, and patient engagement namely, diagnosing and treating patients | ACTIVE | — |
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business management consulting; Business management consulting, business strategic planning services, and business advisory services provided to medical affairs professionals; Consulting services in the field of medical practice business management for others in the field of medical affairs; Consulting services in the field of medical product approval for commercial purposes; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Electronic data processing services relating to information in the field of health; electronic collection of data for market research in the field of health information; commercial management in the field of health; management of health-related information databases | ACTIVE | — |
| 042 | Software development and implementation; programming of computer software for others; pharmaceutical drug development services; medical research laboratory services; scientific research for medical purposes in the field of diagnosing and treating patients; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; provision of information about medical and veterinary research; providing information about scientific and medical research in the field of medical disorders and their treatment; design and development of medical diagnostic apparatus; medical research; medical and pharmacological research services; medical research laboratory; biological research, clinical research in the field of patient engagement; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; analysis of human serum for medical research; blood analysis services for scientific research purposes; computer software development; computer software design; software design and development; computer software consultancy; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for pharmaceutical products for others; providing information on clinical studies via an interactive website; providing information about the results of clinical studies for pharmaceutical products via an interactive website; chemical technological research; technological research relating to computer hardware systems; platform services (PaaS), namely, providing online non-downloadable software for interacting with patients, for providing remote assistance to patients, and for patient engagement, namely, for measuring body functions, measuring cardiac activity and ultrasound purposes, namely, for interpreting the results of ultrasound scans; software services (SaaS), namely, providing online non-downloadable software for interacting with patients, for providing medical treatment and testing of patients, for providing remote assistance to patients, and for patient engagement, namely, for measuring body functions, measuring cardiac activity and ultrasound purposes, namely, for interpreting the results of ultrasound scans; scientific research services for medical purposes; platform as a service (PaaS) featuring computer software platforms for providing access to information in the fields of health, medical or clinical studies; computer programming services for data processing information in the field of health, medical or clinical studies; scientific and medical research and development in the field of diagnosing and treating patients; electronic signature verification services using technology to authenticate user identity; electronic data storage | ACTIVE | — |
| 044 | Health assessment services; conducting health assessment studies for medical diagnostic or treatment purposes; remote monitoring of medical data for medical diagnosis and treatment purposes; medical services connected with medical and clinical studies for diagnostic or treatment purposes; medical assistance; medical clinic services; telediagnosis of diseases; performing telediagnosis of diseases; animal healthcare services; medical advisory services related to patients, medical treatment and diagnostic medical testing of patients; provision of medical services; human healthcare services; medical examinations; medical treatment services; medical health assessment services; medical advisory services relating to medical problems; medical house call services; medical and healthcare services; providing information relating to medical services; medical treatment services provided by clinics and hospitals; consultancy and information services relating to medical products; patient consultancy and information services in the field of medical treatment and diagnostic medical testing of patients; medical services for the treatment of conditions of the human body; medical services for the diagnosis of conditions of the human body; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; managed health care services; medical services; home health care services; medical and healthcare clinics; consulting services relating to health care, namely, consulting in the field of medical treatment and diagnostic medical testing of patients; medical health care consultancy services, namely, consulting in the field of medical treatment and diagnostic medical testing of patients; health care in the nature of health maintenance organizations; medical care; palliative care; nursing care; advisory services relating to weight reduction, namely, consulting to individuals and communities engaged in group weight loss programs; veterinary services; Medical, physical rehabilitation and physical therapy services; dentistry services; psychiatric services; hospital services; chiropractics; homeopathic medical clinic services; beauty salons; barber services; physical therapy; opticians' services; services of a psychologist; sports medicine services; conducting medical physical evaluations; providing medical information; medical counseling; medical analysis services relating to the treatment of patients; pharmaceutical advice; mental health services; telemedicine services; preparation of prescriptions by pharmacists | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alira Health Group Holdings, LLC
- Other trademarks owned by Alira Health Group Holdings, LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PIIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 3, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 3, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 17, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 16, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 16, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 9, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 8, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 7, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 7, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 7, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2024 | NWAP | NEW APPLICATION ENTERED | — |